High Rates of Non-Response Across Treatment Attempts in Chronic Irritable Bowel Syndrome: Results From a Follow-Up Study in Tertiary Care

Objective: Despite a wealth of treatment options for irritable bowel syndrome (IBS), data on the subjective experience of treatments in ongoing clinical practice are sparse. This follow-up study assessed the individual usage of treatment modalities by IBS patients over time and investigated the pati...

Full description

Bibliographic Details
Main Authors: Yuanjun Dong, David Baumeister, Sabrina Berens, Wolfgang Eich, Jonas Tesarz
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fpsyt.2019.00714/full
_version_ 1818293945931661312
author Yuanjun Dong
David Baumeister
Sabrina Berens
Wolfgang Eich
Jonas Tesarz
author_facet Yuanjun Dong
David Baumeister
Sabrina Berens
Wolfgang Eich
Jonas Tesarz
author_sort Yuanjun Dong
collection DOAJ
description Objective: Despite a wealth of treatment options for irritable bowel syndrome (IBS), data on the subjective experience of treatments in ongoing clinical practice are sparse. This follow-up study assessed the individual usage of treatment modalities by IBS patients over time and investigated the patients’ subjective experience of therapeutic impact.Methods: The study was conducted at the Specialty Clinic for Functional Gastrointestinal Disorders of the Heidelberg University Hospital. All patients who fulfilled the Rome III criteria for IBS and treated in our outpatient clinic between January 2012 and December 2016 were invited to the assessment. The primary outcome variables were individual usage of treatment modalities and the Patient Global Impression of Change (PGIC) with treatments.Results: Three hundred and sixty-six patients fulfilled the Rome III criteria for IBS and thus were eligible for this study. Two hundred and seven patients dropped out from the study. The study could include 159 patients (43.7 ± 17.1 years; 71.1% female). The mean time since the first visit to the clinic was 2.8 ± 1.3 years (median 3.0 years). The mean time of symptom duration was 14.1 ± 11.1 years (median 10 years). The average number of treatment attempts was 12, ranging from 2 to 39). With respect to the subjective experience of therapeutic impact, there were no significant differences in the PGIC scores among different treatments (p = 0.183). The rates of non-response rates (minimally improved, no change, or minimally worse) ranged from 63.0% to 83.9%. The PGIC score was correlated negatively with the mean number of treatment attempts (r = −0.316, p < 0.01). The mean number of treatment attempts was correlated negatively with quality of life (r = −0.262, p < 0.01).Conclusion: A multidisciplinary treatment approach of IBS is characterized by high rates of non-response and a high number of frustrating treatment attempts. The connection between the various treatment attempts and the frustrating subjective experience of therapeutic impact puts a substantial burden on IBS patients.
first_indexed 2024-12-13T03:23:55Z
format Article
id doaj.art-e0410ad1990f4f878f969a0f8474bbf7
institution Directory Open Access Journal
issn 1664-0640
language English
last_indexed 2024-12-13T03:23:55Z
publishDate 2019-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychiatry
spelling doaj.art-e0410ad1990f4f878f969a0f8474bbf72022-12-22T00:01:18ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402019-10-011010.3389/fpsyt.2019.00714461108High Rates of Non-Response Across Treatment Attempts in Chronic Irritable Bowel Syndrome: Results From a Follow-Up Study in Tertiary CareYuanjun DongDavid BaumeisterSabrina BerensWolfgang EichJonas TesarzObjective: Despite a wealth of treatment options for irritable bowel syndrome (IBS), data on the subjective experience of treatments in ongoing clinical practice are sparse. This follow-up study assessed the individual usage of treatment modalities by IBS patients over time and investigated the patients’ subjective experience of therapeutic impact.Methods: The study was conducted at the Specialty Clinic for Functional Gastrointestinal Disorders of the Heidelberg University Hospital. All patients who fulfilled the Rome III criteria for IBS and treated in our outpatient clinic between January 2012 and December 2016 were invited to the assessment. The primary outcome variables were individual usage of treatment modalities and the Patient Global Impression of Change (PGIC) with treatments.Results: Three hundred and sixty-six patients fulfilled the Rome III criteria for IBS and thus were eligible for this study. Two hundred and seven patients dropped out from the study. The study could include 159 patients (43.7 ± 17.1 years; 71.1% female). The mean time since the first visit to the clinic was 2.8 ± 1.3 years (median 3.0 years). The mean time of symptom duration was 14.1 ± 11.1 years (median 10 years). The average number of treatment attempts was 12, ranging from 2 to 39). With respect to the subjective experience of therapeutic impact, there were no significant differences in the PGIC scores among different treatments (p = 0.183). The rates of non-response rates (minimally improved, no change, or minimally worse) ranged from 63.0% to 83.9%. The PGIC score was correlated negatively with the mean number of treatment attempts (r = −0.316, p < 0.01). The mean number of treatment attempts was correlated negatively with quality of life (r = −0.262, p < 0.01).Conclusion: A multidisciplinary treatment approach of IBS is characterized by high rates of non-response and a high number of frustrating treatment attempts. The connection between the various treatment attempts and the frustrating subjective experience of therapeutic impact puts a substantial burden on IBS patients.https://www.frontiersin.org/article/10.3389/fpsyt.2019.00714/fullirritable bowel syndrometreatment modalitiessubjective experiencetherapeutic impactresponse rate
spellingShingle Yuanjun Dong
David Baumeister
Sabrina Berens
Wolfgang Eich
Jonas Tesarz
High Rates of Non-Response Across Treatment Attempts in Chronic Irritable Bowel Syndrome: Results From a Follow-Up Study in Tertiary Care
Frontiers in Psychiatry
irritable bowel syndrome
treatment modalities
subjective experience
therapeutic impact
response rate
title High Rates of Non-Response Across Treatment Attempts in Chronic Irritable Bowel Syndrome: Results From a Follow-Up Study in Tertiary Care
title_full High Rates of Non-Response Across Treatment Attempts in Chronic Irritable Bowel Syndrome: Results From a Follow-Up Study in Tertiary Care
title_fullStr High Rates of Non-Response Across Treatment Attempts in Chronic Irritable Bowel Syndrome: Results From a Follow-Up Study in Tertiary Care
title_full_unstemmed High Rates of Non-Response Across Treatment Attempts in Chronic Irritable Bowel Syndrome: Results From a Follow-Up Study in Tertiary Care
title_short High Rates of Non-Response Across Treatment Attempts in Chronic Irritable Bowel Syndrome: Results From a Follow-Up Study in Tertiary Care
title_sort high rates of non response across treatment attempts in chronic irritable bowel syndrome results from a follow up study in tertiary care
topic irritable bowel syndrome
treatment modalities
subjective experience
therapeutic impact
response rate
url https://www.frontiersin.org/article/10.3389/fpsyt.2019.00714/full
work_keys_str_mv AT yuanjundong highratesofnonresponseacrosstreatmentattemptsinchronicirritablebowelsyndromeresultsfromafollowupstudyintertiarycare
AT davidbaumeister highratesofnonresponseacrosstreatmentattemptsinchronicirritablebowelsyndromeresultsfromafollowupstudyintertiarycare
AT sabrinaberens highratesofnonresponseacrosstreatmentattemptsinchronicirritablebowelsyndromeresultsfromafollowupstudyintertiarycare
AT wolfgangeich highratesofnonresponseacrosstreatmentattemptsinchronicirritablebowelsyndromeresultsfromafollowupstudyintertiarycare
AT jonastesarz highratesofnonresponseacrosstreatmentattemptsinchronicirritablebowelsyndromeresultsfromafollowupstudyintertiarycare